ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2018

Oct 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2018-10-01

Reporting Person: MISSLING CHRISTOPHER U (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-01	Stock Option (Right to Buy)	$2.58	A	409500	Acquired	2028-10-01	Common Stock (409500)	Direct

Footnotes

F1: The options shall vest upon the achievement of 50% enrollment in the Company's Alzheimer's disease and Parkinson's disease dementia clinical trials.